We are live on ! Find out more
BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

32 hedge funds and large institutions have $26.1M invested in ProShares Ultra NASDAQ Biotechnology in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

14% more funds holding

Funds holding: 28 → 32 (+4)

10% more capital invested

Capital invested by funds: $23.7M → $26.1M (+$2.4M)

0.73% more ownership

Funds ownership: 6.11% → 6.84% (+0.73%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

9% less call options, than puts

Call options by funds: $16.6M | Put options by funds: $18.3M

Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
11
Reduced
7
Closed
4
Calls
$16.6M
Puts
$18.3M
Net Calls
-$1.73M
Net Calls Change
+$3.63M

Top Buyers

Rank Fund Capital Flow
1
OPPM
Opus Point Partners Management
New York
+$2.22M
2
TRCT
Tower Research Capital (TRC)
New York
+$941K
3
BG
Bellevue Group
Switzerland
+$927K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$712K
5
VKH
Virtu KCG Holdings
New York
+$443K

Top Sellers

Rank Fund Capital Flow
1
MIAN
Mariner Independent Advisor Network
Kansas
-$4.05M
2
PCA
Private Capital Advisors
Connecticut
-$994K
3
TH
Timber Hill
Connecticut
-$721K
4
BA
BKS Advisors
Michigan
-$429K
5
Walleye Trading
Walleye Trading
New York
-$167K
Name Holding Trade Value Shares
Change 		Change in
Stake
OPPM
1
Opus Point Partners Management
New York
$6.97M +$2.22M +45,500 +54%
RIA
2
RPG Investment Advisory
California
$4.9M +$2.68K +55 +0.1%
CIC
3
Chase Investment Counsel
Virginia
$2.48M – – –
TRCT
4
Tower Research Capital (TRC)
New York
$1.45M +$941K +19,287 +248%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$1.27M +$712K +14,597 +159%
BA
6
BKS Advisors
Michigan
$1.27M -$429K -8,800 -27%
TFA
7
Toth Financial Advisory
Virginia
$1.17M +$1.07K +22 +0.1%
PCA
8
Private Capital Advisors
Connecticut
$1.07M -$994K -20,372 -50%
BG
9
Bellevue Group
Switzerland
$1.01M +$927K +19,000 New
BRC
10
Bell Rock Capital
Delaware
$754K +$117K +2,400 +21%
SBIA
11
Sheaff Brock Investment Advisors
Indiana
$543K +$8.54K +175 +2%
VKH
12
Virtu KCG Holdings
New York
$485K +$443K +9,077 New
Morgan Stanley
13
Morgan Stanley
New York
$436K +$113K +2,320 +40%
Citadel Advisors
14
Citadel Advisors
Florida
$401K +$366K +7,500 New
Koshinski Asset Management
15
Koshinski Asset Management
Illinois
$366K – – –
TSS
16
Two Sigma Securities
New York
$297K +$271K +5,559 New
SPC
17
Sigma Planning Corp
Michigan
$258K -$101K -2,079 -30%
WSTAM
18
Wilbanks Smith & Thomas Asset Management
Virginia
$231K +$211K +4,330 New
LPL Financial
19
LPL Financial
California
$214K -$14.4K -295 -7%
Creative Planning
20
Creative Planning
Kansas
$165K -$34.6K -710 -19%
CAL
21
Capital Analysts LLC
Pennsylvania
$92.4K – – –
Bank of America
22
Bank of America
North Carolina
$86K +$24.4K +500 +45%
WA
23
WFG Advisors
Texas
$62K +$11.5K +235 +25%
ASN
24
Advisory Services Network
Georgia
$54K -$3.37K -69 -6%
IA
25
IFP Advisors
Florida
$53K +$48.8K +1,000 New
1
2

BIB Hedge Fund Activity: Q2 2017 in Review

32 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra NASDAQ Biotechnology (BIB) for Q2 2017, worth a combined $26.1M — up 10% from $23.7M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new BIB positions and 4 closed out — a net gain of 4 holders — while 11 added to existing stakes and 7 trimmed.

The largest buyer was Opus Point Partners Management, adding an estimated $2.22M. The largest seller was Mariner Independent Advisor Network, exiting entirely with an estimated $4.05M sold.

  • 32 institutional investors held ProShares Ultra NASDAQ Biotechnology (BIB) as of Q2 2017, up from 28 in Q1 2017.
  • Funds reported $26.1M of ProShares Ultra NASDAQ Biotechnology stock for Q2 2017, up 10% quarter-over-quarter.
  • 8 funds opened new ProShares Ultra NASDAQ Biotechnology positions in Q2 2017 and 4 closed out, a net change of +4 holders.
  • The largest ProShares Ultra NASDAQ Biotechnology buyer in Q2 2017 was Opus Point Partners Management, an estimated $2.22M added.
  • The largest ProShares Ultra NASDAQ Biotechnology seller in Q2 2017 was Mariner Independent Advisor Network, an estimated $4.05M sold.

Based on aggregated 13F filings for Q2 2017.